Former OpenAI science lead founds Warp Sciences, raising $215 million to build robotic drug lab
Former OpenAI science lead Wei Er and three co-founders founded Warp Sciences, raising $215 million and planning to establish a chemistry contract research organization in the United States to provide molecule synthesis and testing services for drug discovery teams. In its first phase, the company will focus on synthesizing analogs for lead compound optimization; clients decide which molecules to study and retain control of their drug programs, and Warp will not develop its own drug pipeline. To train the robots, chemistry researchers will wear camera equipment and sensor gloves to demonstrate and record experimental operations, and the data from each round of experiments will then be used to improve the AI models and subsequent experimental protocols.
Former OpenAI science lead Wei Er and three co-founders founded Warp Sciences, raising $215 million and planning to establish a chemistry contract research organization in the United States to provide molecule synthesis and testing services for drug discovery teams. In its first phase, the company will focus on synthesizing analogs for lead compound optimization; clients decide which molecules to study and retain control of their drug programs, and Warp will not develop its own drug pipeline. To
Matched fieldsBody